Molecular Targets of Synaptic Dysfunction in AD
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004004
Summary
A significant amount of early memory deficit in Alzheimer’s disease (AD) is caused by abnormal communication between nerve cells in the hippocampus, a brain region dedicated to memory formation. Such communication occurs at excitatory synapses, specialized cell-cell contact sites where the neurotransmitter glutamate is released and detected. A prominent form of AD-associated synapse dysfunction is the impairment of synaptic plasticity by beta-amyloid (Aß), the protein fragment that accumulates in the brains of Alzheimer’s patients. A newly recognized mechanism for changing synaptic strength is the removal of neurotransmitter receptors that detect the neurotransmitter glutamate by a process called endocytosis. Dr. Ehlers has found that Aß peptides cause a selective activation of endocytosis molecules with a simultaneous loss of glutamate receptors at hippocampal synapses. Using his preliminary data, Dr. Ehlers is working to define the underlying cellular mechanism of the Aß-dependent disturbance of endocytosis and to identify molecular signals that restore normal synapse function in the amyloid-exposed brain.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University